InvestorsHub Logo

peeved

08/14/21 9:39 AM

#325899 RE: Amatuer17 #325897

Thats a bit of a straw man argument a lot of those should be with the same 2/3 study. It is efficacy after all

dyp

08/14/21 10:33 AM

#325906 RE: Amatuer17 #325897

and that's why Baker has so much money.they invest wisely.
btw
no avxl in the dyp fund.
maybe next week.

Steady_T

08/14/21 11:50 AM

#325919 RE: Amatuer17 #325897

You seems to be ignoring a few things.

Phase 2a - complete.

Dose optimization - complete.

Will anyone take such a drug into their body - Yes.
90 to 95% enroll in OLE. They then request to continue 2-73 after the OLE period is over.